These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1988615)

  • 61. Reshaping the antibody combining site by CDR replacement--tailoring or tinkering to fit?
    Cheetham J
    Protein Eng; 1988 Sep; 2(3):170-2. PubMed ID: 3237679
    [No Abstract]   [Full Text] [Related]  

  • 62. Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.
    Van den Abbeele AD; Aaronson RA; Daher S; Taube RA; Adelstein SJ; Kassis AI
    J Nucl Med; 1991 Jan; 32(1):116-22. PubMed ID: 1988614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antigen protection of monoclonal antibodies undergoing labelling.
    Ramjeesingh M; Zywulko M; Rothstein A; Whyte R; Shami EY
    J Immunol Methods; 1990 Oct; 133(2):159-67. PubMed ID: 2230135
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Recombinant monoclonal antibodies to the Lassa virus: the formation of reactive paratopes].
    Vladyko AS; Kunitskaia LIa; Kras'ko AG; Bystrova SI; Pyzhova NS; Lukashevich IS
    Vopr Virusol; 1990; 35(6):488-92. PubMed ID: 2082553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Thermodynamic parameters of binding of murine antitheophylline monoclonal antibodies 2G3 with theophylline].
    Pokid'ko IuN; Vasilov RG
    Biull Eksp Biol Med; 1997 Apr; 123(4):442-5. PubMed ID: 9190190
    [No Abstract]   [Full Text] [Related]  

  • 66. The advantage of protecting the antigen-binding site during antibody labeling.
    Krohn KA; Eary JF
    J Nucl Med; 1991 Jan; 32(1):122-3. PubMed ID: 1988615
    [No Abstract]   [Full Text] [Related]  

  • 67. Polyreactivity of antibody molecules.
    Notkins AL
    Trends Immunol; 2004 Apr; 25(4):174-9. PubMed ID: 15039043
    [No Abstract]   [Full Text] [Related]  

  • 68. Multiple paths to multispecificity.
    Mariuzza RA
    Immunity; 2006 Apr; 24(4):359-61. PubMed ID: 16618592
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cellular events folowing binding of antigen to lymphocytes.
    Unanue ER
    Am J Pathol; 1974 Oct; 77(1):2-22. PubMed ID: 4614668
    [No Abstract]   [Full Text] [Related]  

  • 70. Mechanisms of virus neutralization by antibody.
    Klasse PJ; Sattentau QJ
    Curr Top Microbiol Immunol; 2001; 260():87-108. PubMed ID: 11443883
    [No Abstract]   [Full Text] [Related]  

  • 71. Lymphocyte receptors for antigen.
    Marchalonis JJ
    J Med; 1974; 5(6):329-67. PubMed ID: 4153398
    [No Abstract]   [Full Text] [Related]  

  • 72. Use of deuterium labelling in NMR studies of antibody combining site structure.
    Anglister J
    Q Rev Biophys; 1990 May; 23(2):175-203. PubMed ID: 2188280
    [No Abstract]   [Full Text] [Related]  

  • 73. Enzyme-inhibiting antibodies and immunoglobulin combining site functional perspectives.
    Petrella RU; Iwamoto M; Yokoyama MM
    Kurume Med J; 1990; 37(4):209-28. PubMed ID: 1711138
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibody: the flexible adaptor molecule.
    Burton DR
    Trends Biochem Sci; 1990 Feb; 15(2):64-9. PubMed ID: 2186517
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.